Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
2005 ◽
Vol 112
(19)
◽
pp. 2940-2945
◽
Keyword(s):
2014 ◽
Vol 8
(7)
◽
pp. 475-480
◽
2015 ◽
Vol 7
(2)
◽
pp. 152
◽
Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats
2016 ◽
Vol 173
(11)
◽
pp. 1805-1819
◽
2014 ◽
Vol 23
(5)
◽
pp. 456-461
◽